ketoconazole oncology
Selected indexed studies
- Modern Management of Mild Autonomous Cortisol Secretion. (Clin Pharmacol Ther, 2019) [PMID:31206616]
- Clinical pharmacokinetics of ketoconazole. (Clin Pharmacokinet, 1988) [PMID:3280211]
- Ketoconazole therapy in advanced prostatic cancer. (J Urol, 1987) [PMID:3573195]
_Worker-drafted node — pending editorial review._
Connections
ketoconazole oncology is a side effect of
Sources
- Modern Management of Mild Autonomous Cortisol Secretion. (2019) pubmed
- Clinical pharmacokinetics of ketoconazole. (1988) pubmed
- Ketoconazole therapy in advanced prostatic cancer. (1987) pubmed
- Systemic candidiasis. (1989) pubmed
- Cushing's disease: adrenal steroidogenesis inhibitors. (2022) pubmed
- The role of ketoconazole in current prostate cancer care. (2018) pubmed
- Rationale for combination ketoconazole/ vitamin D treatment of prostate cancer. (2001) pubmed
- Ketoconazole exacerbates mitophagy to induce apoptosis by downregulating cyclooxygenase-2 in hepatocellular carcinoma. (2019) pubmed
- Editorial comment. (2011) pubmed
- Ketoconazole for the Treatment of Docetaxel-Naïve Metastatic Castration-Resistant Prostate Cancer (mCRPC): A Systematic Review. (2021) pubmed